Kevin Lee Freeman Net Worth

The estimated Net Worth of Kevin Lee Freeman is at least $2.14 Million dollars as of 3 September 2024. Kevin Freeman owns over 7,500 units of Health Catalyst Inc stock worth over $2,034,254 and over the last 2 years Kevin sold HCAT stock worth over $103,125.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Kevin Freeman HCAT stock SEC Form 4 insiders trading

Kevin has made over 2 trades of the Health Catalyst Inc stock since 2024, according to the Form 4 filled with the SEC. Most recently Kevin sold 7,500 units of HCAT stock worth $54,150 on 3 September 2024.

The largest trade Kevin's ever made was selling 7,500 units of Health Catalyst Inc stock on 3 September 2024 worth over $54,150. On average, Kevin trades about 1,364 units every 8 days since 2022. As of 3 September 2024 Kevin still owns at least 255,881 units of Health Catalyst Inc stock.

You can see the complete history of Kevin Freeman stock trades at the bottom of the page.

What's Kevin Freeman's mailing address?

Kevin's mailing address filed with the SEC is C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN, UT, 84095.

Insiders trading at Health Catalyst Inc

Over the last 5 years, insiders at Health Catalyst Inc have traded over $32,461,176 worth of Health Catalyst Inc stock and bought 554,600 units worth $5,926,241 . The most active insiders traders include Daniel D. Burton, Mark B Templeton, and Paul Horstmeier. On average, Health Catalyst Inc executives and independent directors trade stock every 8 days with the average trade being worth of $135,905. The most recent stock trade was executed by Benjamin Landry on 6 September 2024, trading 2,466 units of HCAT stock currently worth $18,224.

What does Health Catalyst Inc do?

health catalyst is dedicated to enabling health care organizations to fundamentally improve care by building the most comprehensive and fully integrated suite of healthcare data warehousing and process improvement solutions available. health catalyst was formed by a group of healthcare veterans with vast data warehousing and quality improvement experience. our founders and executives collaborated for nearly a decade to revolutionize clinical process models using analytics. during development, they faced numerous hurdles in the quest to develop a data warehouse that could handle the complexities unique to healthcare data. after determining that the predominant approaches to data modeling weren’t effective for healthcare data, they discovered the solution, which is now known as the adaptive data architecture. using a late-binding bus architecture, catalyst’s adaptive data model is agile, flexible, and can be implemented in a matter of weeks compared to the months or years traditional app

Complete history of Kevin Freeman stock trades at Health Catalyst Inc

Health Catalyst Inc executives and stock owners

Health Catalyst Inc executives and other stock owners filed with the SEC include:

• Daniel Burton,
  Chief Executive Officer, Director
• Paul Horstmeier,
  Chief Operating Officer
• J. Patrick Nelli,
  Chief Financial Officer
• Daniel D. Burton,
  CEO & Director
• Paul Horstmeier,
  Chief Operating Officer
• J. Patrick Nelli Jr.,
  Pres
• Daniel H. Orenstein,
  Gen. Counsel & Sec.
• Linda Llewelyn,
  Chief People Officer
• John Kane,
  Independent Director
• Fraser Bullock,
  Independent Chairman of the Board
• Michael Dixon,
  Independent Director
• Duncan Gallagher,
  Independent Director
• Todd Cozzens,
  Independent Director
• Anita Pramoda,
  Independent Director
• Timothy Ferris,
  Director
• Adam Brown,
  Senior Vice President - Investor Relations
• S. Dawn Smith,
  Independent Director
• Julie Larson-Green,
  Independent Director
• Daniel Orenstein,
  General Counsel, Corporate Secretary
• Amanda Hundt,
  Vice President - Corporate Communications
• Linda Llewelyn,
  Chief People Officer
• Kyle J. Salyers,
  Sr. VP of Corp. Devel.
• Jason Jones,
  Chief Analytics & Data Science Officer and GM of Data & Analytics Platform
• Dave Ross,
  Chief Technology Officer
• Trudy Sullivan,
  Chief Communications and Diversity, Equity & Inclusion Officer
• Bryan Richard Hinton,
  Chief Technology Officer
• Jason Alger,
  Chief Accounting Officer
• Bryan Truman Hunt,
  Chief Financial Officer
• Dale Sanders,
  Chief Technology Officer
• Venture Partners Xi, Lp Nor...,
  
• Us (Ttgp), Ltd.Scgf V Manag...,
  
• Promod Haque,
  10% owner
• Mark B Templeton,
  
• Bryan Truman Hunt,
  Chief Financial Officer
• Bryan Richard Hinton,
  Chief Technology Officer
• Kevin Lee Freeman,
  Chief Commercial Officer
• Jason Alger,
  Chief Financial Officer
• Daniel Le Sueur,
  Chief Operating Officer
• Anne Marie Bickmore,
  COO and Chief Product Officer
• Benjamin Landry,
  General Counsel